Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor | Anticancer Research
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
High-fidelity of Five Quasimonomorphic Mononucleotide Repeats to High-frequency Microsatellite Instability Distribution in Early-stage Adenocarcinoma of the Colon | Anticancer Research
Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study
Clinical relevance of microsatellite instability in colorectal cancer. | Semantic Scholar
Should mismatch repair status be determined in all stage II and III colon cancer patients? | Colorectal Cancer
CCIs in colon cancer with MSS and MSI. The directions and number of... | Download Scientific Diagram
MSI Testing and IHC
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes - ScienceDirect
Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer | Cancer Biology & Medicine
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability - ScienceDirect
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms | British Journal of Cancer
Microsatellite instability: a review of what the oncologist should know | Cancer Cell International | Full Text
Cancers | Free Full-Text | Neoadjuvant Immunotherapy for Patients with dMMR/ MSI-High Gastrointestinal Cancers: A Changing Paradigm
Microsatellite instability in colorectal cancer—the stable evidence | Nature Reviews Clinical Oncology
Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient | Journal of Human Genetics
IJMS | Free Full-Text | Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer
Role of CIN and MSI pathways in colon cancer progression. | Download Scientific Diagram
Pathology Outlines - Colon cancer biomarker testing (including MSI / Lynch)
L'immunothérapie dans le traitement du cancer colorectal - NetCancer
Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer | BMC Cancer | Full Text
